Tvardi Therapeutics, Inc. (TVRD) — Cash Flow-to-Debt Ratio
Tvardi Therapeutics, Inc. (TVRD) has a Cash Flow-to-Debt Ratio of -0.38x as of September 2025, meaning its operating cash flow of $-4.26 Million could theoretically repay 0% of its total liabilities ($11.15 Million) in one year. See TVRD net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Tvardi Therapeutics, Inc. Cash Flow-to-Debt Ratio (2020–2024)
Historical debt coverage capacity for Tvardi Therapeutics, Inc. across 5 annual periods. Also explore Tvardi Therapeutics, Inc. (TVRD) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Tvardi Therapeutics, Inc. (2020–2024)
Year-by-year debt coverage analysis for Tvardi Therapeutics, Inc.. For market capitalisation and broader financial context, see Tvardi Therapeutics, Inc. market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.26x | $-60.92 Million | $48.42 Million | ▼ -432.5% |
| 2023 | -0.24x | $-21.04 Million | $89.06 Million | ▼ -19.2% |
| 2022 | -0.20x | $-17.87 Million | $90.15 Million | ▲ +93.6% |
| 2021 | -3.08x | $-60.09 Million | $19.53 Million | ▼ -1142.1% |
| 2020 | -0.25x | $-5.49 Million | $22.16 Million | — |